Remdesivir Receives Approval from FDA, First Among for COVID-19 Treatment
The Food and Drug Administration authorized Remdesivir for the treatment of patients over the age of 12 who have been admitted with the Covid-19 disease.
Full Article
Remdesivir Receives Approval from FDA, First Among for COVID-19 Treatment
HNGN
0 shares
1 views
You might like
Related news coverage
AIM ImmunoTech CEO Thomas Equels named Entrepreneur of the Year by BioFlorida
Proactive Investors
AIM ImmunoTech Inc (NYSEAMERICAN:AIM) announced Friday that CEO Thomas Equels has been named the Weaver H Gaines Entrepreneur of..
-
NA Proactive news snapshot: ElectraMeccanica Vehicles, Willow Biosciences, DRDGOLD Limited, Aurania Resources UPDATE ...
Proactive Investors
-
NA Proactive news snapshot: DGTL Holdings, First Cobalt, American Resources, Progressive Planet, Silver Range Resources, African Gold Group UPDATE...
Proactive Investors
-
Gilead Sciences says remdesivir plays important role for COVID-19 patients treatment
Proactive Investors
-
Supreme Court takes into account WHO report on Remdesivir, seeks Centre's response
Mid-Day
Advertisement
More coverage
New COVID-19 Cases And Hospitalizations Up; Deaths May Follow
Newsy
Watch VideoHospitals are bracing for another surge of COVID-19 patients. In parts of Texas, COVID-19 hospitalizations have roughly..
